Latest News

James Cameron Sounds Alarm Over Netflix-Warner Bros. Deal, Backs Paramount

February 20, 2026 at 12:36 AM
By Winston Cho
The director's chief concern is the proposed merger's impact on movie theaters, which depend on money from tentpoles that he claims may see shorter theatrical releases or be sent directly to streaming if Netflix prevails.
The director's chief concern is the proposed merger's impact on movie theaters, which depend on money from tentpoles that he claims may see shorter theatrical releases or be sent directly to streaming if Netflix prevails. James Cameron attends the world premiere of 20th Century Studios 'Avatar: Fire and Ash' at The Dolby Theatre in Hollywood, California on December 1, 2025. Rodin Eckenroth/Getty Images for 20th Century Studios Share on Facebook Share on X Google Preferred Share to Flipboard Show additional share options Share on LinkedIn Share on Pinterest Share on Reddit Share on Tumblr Share on Whats App Send an Email Print the Article Post a Comment Logo text James Cameron is going to bat for Paramount in the bidding war for Warner Bros. Discovery. In a letter sent to Sen. Mike Lee (R-Utah), Cameron argues that allowing Netflix to purchase the studio will deal a disastrous blow to movie theaters and weaken an essential cog of the Hollywood machinery in a way that will lead to substantial job losses. The letter, dated Feb. 10, amplifies concerns from lawmakers and the Justice Department that the potential sale will result in fewer films being released in theaters. While the government’s main focus has been Netflix’s dominance in streaming, it’s also pressed Netflix on what will happen to Warner Bros. movies if it were to acquire the company. Related Stories Business Paramount's Savvy Legal Maneuver for Warner Bros. Alarms Democratic Senators Movies James Cameron Celebrates Finally Being Honored for Screenwriting: "Been Writing These for 50 Years" Cameron nods to prior remarks from Netflix CEO Ted Sarandos calling movie theaters an “outdated concept” and an “outmoded idea.” “The business model of Netflix is directly at odds with the theatrical film production and exhibition business, which employs hundreds of thousands of Americans,” he writes in the missive, first published by CNBC. “It is therefore directly at odds with the business model of the Warner Brothers movie division, one of the few remaining major movie studios.” Warner Bros. releases roughly 15 movies per year in theaters. Cameron, and others in Hollywood, are concerned that Netflix will lower that figure. “It will be a blow to the exhibition community (theater owners and their tends of thousands of employees) at a critical time to have this production output redirected to streaming,” the letter states. If movie theaters see less business, the entire industry will suffer, Cameron says. If tentpoles are “no longer green-lit because the market contracts further,” he writes, “then many jobs will be lost.” He adds, “Theaters will close. Fewer films will be made. Service providers such as VFX companies will go out of business. The job losses will spiral.” Testifying before the Senate subcommittee on antitrust earlier this month, Sarandos committed a 45-day theatrical window when asked by lawmakers of the deal’s impact on theaters. Color Cameron skeptical. He argues Netflix will likely change course in a few years since theatrical releases fundamentally clash with its business model. The letter states, “What are the teeth in the deal? What administrative body will hold them to task if they slowly sunset their so-called commitment to theatrical releases? But once they own a major movie studio, that is irrevocable. That ship has sailed.” Cameron also says the pledge doesn’t mean anything unless Sarandos specifies the number of theaters Warner Bros. movies will be displayed. “Netflix has done only a handful of theatrical releases, and only then under pressure from prestigious filmmakers,” he writes. “But these are usually in a token number of theaters, and are mostly done to qualify for Academy Awards. These releases do not represent the bread-and-butter of the exhibition business.” Cameron positions Netflix acquiring Warner Bros. as a bad deal for both consumers, who will get to see fewer movies, and filmmakers, who will see fewer choices for studios interested in investing in their projects. One avenue the government could pursue to block the deal is a monopsony theory, or whether the combined company would have too much power over creators and talent. “I am but a humble movie farmer,” Cameron writes. “And I see my future creativity and productivity directly threatened by this proposed sale.” In an interview last year on The Town podcast, Cameron endorsed the David Ellison-led company’s bid for Warner Bros. “I think Paramount’s the best choice,” he said. “Netflix would be a disaster. Sorry, Ted, but geez. Sarandos has gone on the record saying theatrical films are dead. ‘Theatrical is dead.’ Quote, unquote.” Read More About: James Cameron Paramount Warner Bros. Discovery THR Newsletters Sign up for THR news straight to your inbox every day Subscribe Sign Up More from The Hollywood Reporter casey wasserman Wasserman Retains Investment Bank as Sale Process Kicks Into Gear
Share:

Help us improve this article. Share your feedback and suggestions.

Related Articles

James Cameron Doesn’t Quite Tell Senator That Netflix Buying WB Is Cinema Equivalent Of Shuffling Deck Chairs On The Titanic, But Mega-Director Gets Pretty Close

James Cameron Doesn’t Quite Tell Senator That Netflix Buying WB Is Cinema Equivalent Of Shuffling Deck Chairs On The Titanic, But Mega-Director Gets Pretty Close

James Cameron may sarcastically call himself a “humble movie farmer,” but the Oscar winning blockbuster director wants the folks in DC to know it’s no joke when he says “the proposed sale of Warner Brothers Discovery to Netflix will be disastrous for the theatrical motion picture business.” New Zealand-based Cameron is no fan of Donald [
]

Feb 20, 2026
Eric Dane Dies: ‘Euphoria’ & ‘Grey’s Anatomy’ Star Was 53

Eric Dane Dies: ‘Euphoria’ & ‘Grey’s Anatomy’ Star Was 53

Eric Dane, the actor known for his roles in Euphoria and Grey’s Anatomy, has died. He was 53. Following the actor’s ALS diagnosis, which he has opened up about over the past year, his family announced that he died on Thursday. “With heavy hearts, we share that Eric Dane passed on Thursday afternoon following a [
]

Feb 20, 2026
📰

Eric Dane, ‘Grey’s Anatomy’ Star, Dead at 53 Following ALS Battle

The news arrives 10 months after the Euphoria actor revealed he had been diagnosed with amyotrophic lateral sclerosis

Feb 20, 2026
📰

Eric Dane, Dr. Mark “McSteamy” Sloan on ‘Grey’s Anatomy,’ Dies at 53

His career took off after he emerged from a shower with a strategically placed towel on the ABC hit. Later, he starred on ‘The Last Ship’ and ‘Euphoria.’

Feb 20, 2026
Eric Dane, ‘Grey’s Anatomy’ and ‘Euphoria’ Star, Dies at 53

Eric Dane, ‘Grey’s Anatomy’ and ‘Euphoria’ Star, Dies at 53

Eric Dane, best known for his role as Dr. Mark Sloan (“McSteamy”) on “Grey’s Anatomy” and as complicated father Cal Jacobs on “Euphoria,” died February 19, his family confirmed to People Magazine. Dane was diagnosed with amyotrophic lateral sclerosis, known as Lou Gehrig’s disease, in 2025. “With heavy hearts, we share that Eric Dane passed on [
]

Feb 20, 2026
Sarah Michelle Gellar Praises Mckenna Grace’s ‘Scooby-Doo’ Casting As “Perfect”

Sarah Michelle Gellar Praises Mckenna Grace’s ‘Scooby-Doo’ Casting As “Perfect”

As Mckenna Grace prepares to unmask some monsters in Netflix’s live-action Scooby-Doo series, she’s got the support of Mystery Inc. past. Sharing Deadline’s reporting that Grace will play Daphne in the eight-episode series, her predecessor Sarah Michelle Gellar gave the actress her stamp of approval with a mention on her Instagram Story. “You are going [
]

Feb 20, 2026

Cookie Consent

We use cookies to enhance your browsing experience, analyze site traffic, and serve personalized ads. By clicking "Accept", you consent to our use of cookies. You can learn more about our cookie practices in our Privacy Policy.